KIANA TATUM: Open Payments
NPI 1346728169 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 10 payments from 5 companies in 2025. Trend: 2023 $926 · 2024 $410 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 5 | $116 |
| GENZYME CORPORATION | 2 | $66 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| ACADIA Pharmaceuticals Inc | 1 | $20 |
| Amgen Inc. | 1 | $17 |
Products named: Arikayce, LEQVIO, NUPLAZID, FABRAZYME.
Industry payments across TX — which companies pay providers there.
